Attention: All compounds listed are strictly for laboratory research purposes only. Not for human consumption.

The Dawn of Cellular Optimization

A vertically integrated biotech ecosystem combining elite-purity peptide manufacturing with programmatic regenerative clinic deployment.

View Lab Specifications

Label & Vial Architecture

Standardized presentation layouts for raw materials procurement and synthesis partner verification.

EOS PEPTIDES
BPC-157
10 mg
FOR RESEARCH USE ONLY
CAS: 137525-51-0
PURITY: ≥99.0% HPLC Verified

Synthesis Packaging Matrix

Provide these exact structural criteria to overseas production facilities when requesting quote tallies to avoid generic packaging inconsistencies.

Vial Component 3mL Clear Borosilicate Glass (Type I)
Stopper Element 13mm Chlorobutyl Rubber (FluroTec Coated)
Crimp Enclosure 13mm Crimson/Deep-Teal Flip-Off Cap
Regulatory Text Imprinted: "For Research Use Only"

Primary Biologics Pipeline

Targeted amino acid sequence stacks optimized for tissue synthesis and cellular repair research protocols.

Sequence Focus I
Research Only

BPC-157

Body Protection Compound (Pentadecapeptide)

Engineered to accelerate angiogenic pathways and soft tissue repair, targeting localized fibroblasts to optimize tendon, ligament, and gastric mucosal recovery mechanisms.

  • Purity Standard: ≥ 99.0% Lyophilized
  • CAS Registry: 137525-51-0
  • Regulatory Status: Laboratory Reagent
Sequence Focus II
Research Only

TB-500

Thymosin Beta-4 Derivative (Acetylated Peptide)

A precision-synthesized cellular actin-sequestering molecule utilized to upregulate endothelial cell differentiation, systemic healing mechanics, and rapid muscle recovery structural repair pathways.

  • Purity Standard: ≥ 99.0% Lyophilized
  • CAS Registry: 77591-33-4
  • Regulatory Status: Laboratory Reagent

The Vertical Edge

Most advanced clinical environments are entirely disconnected from the logistics of their supply chain. Eos Regenerative bridges this structural gap natively.

By coupling an institutional-grade compounding supply pipeline with premium wellness and anti-aging clinic infrastructure, we insulate our patient ecosystem from retail volatility while maintaining unmatched clinical margin controls.

Initial Target Metrics

15,000
Total Vial Volume Production Target
Wolverine Stack
Co-Formulation System Tier Allocation